Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
A Seamless, Phase 1b/2 Multiple Ascending Dose/Proof of Concept Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations
A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis
Pulmonary Sarcoidosis
Xentria, Inc.NCT05890729
Phase 2
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of a 12-week Administration of OATD-01, an Oral Inhibitor of Chitinase-1 (CHIT1), for the Treatment of Active Pulmonary Sarcoidosis (the KITE Study)
This is a Phase 2, randomized, double-blind, placebo-controlled, adaptive, multicenter study to evaluate the efficacy, safety, tolerability, Pharmacodynamics (…
Pulmonary Sarcoidosis
Molecure S.A.NCT06205121
Role of Genetic Factors in the Pathogenesis of Lung Disease
This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved in the process of breathing and examini…
Cystic FibrosisPulmonary FibrosisTuberous Sclerosis+2 more
National Heart, Lung, and Blood Institute (NHLBI)NCT00001532